CBIO (STOCKS)
Crescent Biopharma, Inc. Common Stock
$16.630000
+0.200000 (+1.22%)
Prev close: $16.430000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Joshua T. Brumm
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $682.10M
- Employees
- 44
- P/E (TTM)
- -2.17
- P/B (TTM)
- 2.86
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.74 | $-0.81 | +0.0709 | +8.74% |
|
Mar 2026 (Q1)
|
$-0.70 | $-0.97 | +0.2655 | +27.50% |
|
Dec 2025 (Q4)
|
$-0.54 | $-2.57 | +2.0266 | +78.96% |
|
Sep 2025 (Q3)
|
$-1.27 | $-2.02 | +0.7516 | +37.18% |